Ticker > Company >

Titan Bio-Tech share price

Titan Bio-Tech Ltd.

BSE: 524717 SECTOR: Chemicals  75k   843   86

476.25
0 0
BSE: 25 Apr 04:01 PM

Price Summary

Today's High

₹ 504

Today's Low

₹ 460.25

52 Week High

₹ 1017.85

52 Week Low

₹ 406.7

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

393.56 Cr.

Enterprise Value

397.89 Cr.

No. of Shares

0.83 Cr.

P/E

20.34

P/B

2.78

Face Value

₹ 10

Div. Yield

0.42 %

Book Value (TTM)

₹  171.09

CASH

2.84 Cr.

DEBT

7.17 Cr.

Promoter Holding

55.88 %

EPS (TTM)

₹  23.41

Sales Growth

13.94%

ROE

20.18 %

ROCE

26.3%

Profit Growth

12.55 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year13.94%
3 Year10.24%
5 Year23.02%

Profit Growth

1 Year12.55%
3 Year-6.31%
5 Year50.35%

ROE%

1 Year20.18%
3 Year23.52%
5 Year28.79%

ROCE %

1 Year26.3%
3 Year29.89%
5 Year33.99%

Debt/Equity

0.0558

Price to Cash Flow

18.61

Interest Cover Ratio

27.9479

CFO/PAT (5 Yr. Avg.)

0.876937675504616

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2025 55.88 0.00
Dec 2024 55.88 0.00
Sep 2024 55.88 0.00
Jun 2024 55.88 0.00
Mar 2024 55.88 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 23.5205% over the past 3 years.
  • Company has been maintaining healthy ROCE of 29.8937% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 27.9479.
  • The Company has been maintaining an effective average operating margins of 23.3087470173132% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 2.9711.
  • The company has a high promoter holding of 55.88%.

 Limitations

  • The company has shown a poor profit growth of -6.30902324240844% for the Past 3 years.
  • The company has shown a poor revenue growth of 10.2420204644142% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
Net Sales 45.98 39.92 43.12 39.89 38.28
Total Expenditure 35.38 32.84 34.87 32.13 33.43
Operating Profit 10.6 7.08 8.25 7.76 4.85
Other Income 0.44 0.48 0.62 0.32 1.59
Interest 0.26 0.34 0.31 0.27 0.15
Depreciation 0.84 0.84 1.05 1.1 1.18
Exceptional Items 0 0 0 0 0
Profit Before Tax 9.94 6.38 7.52 6.72 5.11
Tax 2.56 1.53 1.82 1.71 1.3
Profit After Tax 7.38 4.84 5.7 5 3.8
Adjusted EPS (Rs) 8.94 5.86 6.9 6.06 4.6

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 69.48 122.46 123.55 144 164.07
Total Expenditure 58.6 80.59 92.28 114.48 129.79
Operating Profit 10.88 41.87 31.27 29.52 34.28
Other Income 0.41 0.66 0.94 1.94 1.75
Interest 1.91 1.33 0.87 0.75 1.17
Depreciation 1.75 2.1 2.37 2.6 3.33
Exceptional Items 0.61 -0.32 0 0 0
Profit Before Tax 8.24 38.76 28.97 28.12 31.53
Tax 2.04 9.99 7.28 7.09 7.87
Net Profit 6.2 28.77 21.68 21.02 23.66
Adjusted EPS (Rs.) 7.5 34.82 26.24 25.44 28.64

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 8.26 8.26 8.26 8.26 8.26
Total Reserves 29.55 57.56 77.98 97.83 120.18
Borrowings 8.48 1.83 1.08 0.3 0.45
Other N/C liabilities 2.44 3.99 3.82 3.95 3.55
Current liabilities 17.93 24.3 23.99 27.54 26.91
Total Liabilities 66.66 95.94 115.13 137.88 159.36
Assets
Net Block 25.24 27.04 34.99 35.89 52.01
Capital WIP 0 0.27 3.63 13.29 2.53
Intangible WIP 0 0 0 0 0.02
Investments 1.27 1.27 4.03 11.59 23.18
Loans & Advances 0.58 7.77 1.52 1.35 1.29
Other N/C Assets 0 0.18 0.16 0.26 0.36
Current Assets 39.57 59.4 70.79 75.49 79.96
Total Assets 66.66 95.94 115.13 137.88 159.36
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 8.24 38.76 28.97 28.12 31.53
Adjustment 3.86 3.62 3.52 3.52 4.76
Changes in Assets & Liabilities -3.64 -14.64 -3.33 -2.96 -7.28
Tax Paid -1.54 -10.16 -7.12 -7.5 -7.87
Operating Cash Flow 6.92 17.59 22.04 21.18 21.15
Investing Cash Flow -0.94 -4.17 -16.44 -20.73 -20.3
Financing Cash Flow -5.87 -9.81 -4.1 -2.4 -2.87
Net Cash Flow 0.11 3.61 1.51 -1.95 -2.02

Corporate Actions

Investors Details

PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
promoters 55.88 55.88 55.88 55.88 55.88
connoisseur management se... 6.78 6.78 6.78 6.78 6.78
madhu gupta 0.80 0.80 0.80 0.80 0.80
manju singla 0.86 0.86 0.86 0.86 0.86
naresh kumar singla 0.42 0.42 0.42 0.42 0.42
naresh kumar singla huf 0.12 0.12 0.12 0.12 0.12
raja singla 0.74 0.74 0.74 0.74 0.74
ravinder gupta 0.10 0.10 0.10 0.10 0.10
shivom singla 0.43 0.43 0.43 0.43 0.43
supriya singla 0.66 0.66 0.66 0.66 0.66
suresh chand singla 1.28 1.28 1.28 1.28 1.28
tanita leasing & finance ... 9.49 9.49 9.49 9.49 9.49
titan securities ltd 33.59 33.59 33.59 33.59 33.59
udit singla 0.61 0.61 0.61 0.61 0.61
PARTICULARS Mar 2024% Jun 2024% Sep 2024% Dec 2024% Mar 2025%
investors 44.12 44.12 44.12 44.12 44.12
ankit goyal - - - - 1.57
investor education and pr... 8.81 8.81 8.80 9.29 9.28
manish goel - - 1.57 1.65 -
mukesh panjwani 1.13 1.15 - - -

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Titan Biotech informs about newspaper advertisements 13 Feb, 12:59 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:37 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:37 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:37 PM Titan Biotech informs about details of loss of certificate 10 Dec, 4:50 PM Titan Biotech informs about issuance of letter of confirmation 5 Dec, 5:32 PM Titan Biotech informs about issuance of letter of confirmation 16 Nov, 2:20 PM Titan Biotech informs about loss of share certificate 24 Oct, 3:15 PM Titan Biotech informs about press release 9 Sep, 3:09 PM Titan Biotech informs about loss of share certificate 13 Aug, 5:34 PM Titan Bio-Tech - Quaterly Results 13 Aug, 3:42 PM Titan Biotech informs about loss of share certificates 17 Jul, 11:14 AM Titan Biotech informs about loss of share certificate 26 Jun, 5:22 PM Titan Bio-Tech - Quaterly Results 29 May, 3:49 PM Titan Biotech informs about certificate 6 Apr, 12:07 PM Titan Biotech informs about issue of duplicate share certificate 5 Mar, 5:14 PM Titan Biotech to acquire stake in Titan Media 12 Feb, 5:14 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:44 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:44 PM Titan Bio-Tech - Quaterly Results 12 Feb, 3:44 PM Titan Biotech informs about details of loss of certificate 24 Nov, 5:04 PM Titan Biotech informs about loss of shareholder certificate 31 Oct, 5:11 PM Titan Bio-Tech - Quaterly Results 10 Aug, 3:46 PM Titan Bio-Tech - Quaterly Results 10 Aug, 3:46 PM Titan Biotech informs about details of loss of certificate 4 Aug, 4:46 PM Titan Biotech informs about compliance certificate 7 Jul, 5:27 PM Titan Bio-Tech - Quaterly Results 29 May, 3:54 PM Titan Bio-Tech - Quaterly Results 29 May, 3:54 PM Titan Biotech informs about loss of share certificate 10 Apr, 5:03 PM Titan Biotech informs about issuance of duplicate share certificate 23 Mar, 12:16 PM Titan Biotech informs about loss of share certificate 21 Mar, 11:42 AM Titan Bio-Tech - Quaterly Results 4 Feb, 4:05 PM Titan Bio-Tech - Quaterly Results 4 Feb, 4:05 PM Titan Bio-Tech - Quaterly Results 4 Feb, 4:05 PM Titan Biotech informs about board meeting 27 Jan, 12:41 PM Titan Biotech informs about certificate 7 Jan, 12:17 PM Titan Biotech informs about issuance of duplicate share certificates 26 Nov, 12:31 PM Titan Bio-tech informs about loss of share certificate 17 Nov, 12:47 PM Titan Bio-Tech - Quaterly Results 14 Nov, 3:34 PM Titan Biotech informs about details of loss of certificate 16 Aug, 2:44 PM Titan Bio-Tech - Quaterly Results 10 Aug, 5:38 PM Titan Biotech informs about compliances-certificate 13 Jul, 4:19 PM Titan Biotech informs about newspaper publication 2 Jul, 1:54 PM Titan Biotech informs about issuance of duplicate share certificate 25 Jun, 11:23 AM Titan Biotech informs about issue of duplicate certificates 14 Jun, 5:01 PM Titan Biotech informs about issue of duplicate certificate 8 Jun, 2:31 PM Titan Biotech informs about loss of share certificate 18 May, 5:02 PM Titan Bio-tech informs about issuance of duplicate share certificate 25 Apr, 5:02 PM Titan Bio-Tech - Quaterly Results 9 Feb, 3:33 PM Titan Bio-Tech - Quaterly Results 9 Feb, 3:33 PM

Titan Bio-Tech Stock Price Analysis and Quick Research Report. Is Titan Bio-Tech an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Titan Bio-Tech stock price today is Rs 476.25. Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Titan Bio-Tech . 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Titan Bio-Tech has a PE ratio of 20.3410896417406 which is high and comparatively overvalued .

  • Share Price: - The current share price of Titan Bio-Tech is Rs 476.25. One can use valuation calculators of ticker to know if Titan Bio-Tech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Titan Bio-Tech has ROA of 15.9219 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Titan Bio-Tech has a Current ratio of 2.9711 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Titan Bio-Tech has a ROE of 20.1789 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Titan Bio-Tech has a Debt to Equity ratio of 0.0558 which means that the company has low proportion of debt in its capital.

  • Sales growth: - Titan Bio-Tech has reported revenue growth of 13.9395 % which is poor in relation to its growth and performance. 

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Titan Bio-Tech for the current financial year is 20.8941069200675 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Titan Bio-Tech is Rs 2 and the yield is 0.4199 %.

  • Earnings Per Share: - It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Titan Bio-Tech is Rs 23.4132 . The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Titan Bio-Tech in Ticker for free. Also, one can get the intrinsic value of Titan Bio-Tech by using Valuation Calculators, which are available with a Finology ONE subscription. 

Last Updated on:
Brief about Titan Bio-Tech
X